Markets & Industries
    Stock Market Today:
    February 27, 2015
     CurrentToday's Change
    NASDAQ4,978.59-9.30-0.19%
    S&P 5002,109.50-1.24-0.06%
    DOW18,182.39-32.03-0.18%
    Russell 20001,237.34-1.78-0.14%
    NASDAQ
    All data as of 11:32 AM Feb 27, 2015. Delayed at least 15 minutes
    Featured Commentaries
    Market Commentaries
    Fourth-Quarter Gross Domestic Product Is Revised From 2.6% to 2.2%
    Harvey S. Katz, CFA  |  02/27/2015
    The U.S. economy, which had slowed its rate of improvement during the fourth quarter to begin with, as the initial estimate of the period's gross domestic product had shown a reduction from 5.0% in the July-through-September term to 2.6% in the latest stanza, has seen that latter rate dwindle further, to 2.2% in the period's first revision.
    Market Daily Updates
    Stock Market Today: February 26, 2015
    Harvey S. Katz, Matthew E. Spencer, Simon E. Shnayder, Adam Rosner  |  02/26/2015
    The U.S. stock market put in a somewhat choppy session today, and ultimately ended on a mixed note. At the close of the session, the Dow Industrial Average was off just 10 points; the broader S&P 500 Index was also down three points; while the NASDAQ was ahead 21 points.
    StockCommentary
    Retail Roundup: February 26, 2015
    Andre J. Costanza  |  02/26/2015
    Retailers continue to post mixed results as the operating landscape of the industry remains a bit perplexing. Indeed, holiday season results have been all over the place despite what seems to be overall improving consumer confidence trends.
    Market Daily Updates
    Stock Market Today: February 25, 2015
    Harvey S. Katz, Matthew E. Spencer, Adam Rosner, William G. Ferguson  |  02/25/2015
    It was a nondescript day of trading on Wall Street today, with the major equity averages never straying too far from the neutral line. The major indexes spent much of the first half of trading modestly higher, following an initial drop, with continued support coming in the form of dovish comments by Federal Reserve Chair Janet Yellen, who concluded her two-day testimony before Congress.
    StockHighlights
    Using a Value Line Report: Johnson & Johnson
    Paul E. Debbas, CFA  |  02/25/2015
    Johnson & Johnson (JNJ) is one of the largest companies in the world. It has brand names that are familiar to most consumers, such as Band-Aid, Tylenol, and Listerine. The company also sells pharmaceuticals and medical devices. Indeed, J&J has a long track record of success, as shown in the Statistical Array. Earnings and dividends per share have risen every year since the turn of the century, and the company’s record of earnings and dividend growth actually goes back far longer than the figures on our page (31 years for earnings, 52 years for dividends). Returns on equity have consistently been above 20%. Profit margins are high, as well. However, the company is facing some challenges.
    • Video Commentary
      Value Line Website Tutorial: The New Digital Stock Report

      An unexpected error has occurred.

      The appropriate people have been notified of this error, and will be working to correct the problem as soon as possible.Thank you for your patience.
      • Research Notes
        Feb 27, 2015
        Please sign in to read more.
        Feb 27, 2015
        Please sign in to read more.
        Feb 27, 2015
        Please sign in to read more.
        Feb 27, 2015
        Please sign in to read more.
        Feb 27, 2015
        Please sign in to read more.

        An unexpected error has occurred.

        The appropriate people have been notified of this error, and will be working to correct the problem as soon as possible.Thank you for your patience.